UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Is Biological Subtype Prognostic of Locoregional Recurrence Risk in Women With pT1-2N0 Breast Cancer Treated With Mastectomy?

International journal of radiation oncology, biology, physics, 2014, Vol.88 (1), p.57-64

2014

Volltextzugriff (PDF)

pN0(i+) Breast Cancer: Treatment Patterns, Locoregional Recurrence, and Survival Outcomes

International journal of radiation oncology, biology, physics, 2013-11, Vol.87 (4), p.731-737

2013

Volltextzugriff (PDF)

Individual investigator profiles of biospecimen use in cancer research

Biopreservation and biobanking, 2014-06, Vol.12 (3), p.192

2014

Volltextzugriff (PDF)

Exploring phlebotomy technique as a pre-analytical factor in proteomic analyses by mass spectrometry

Genome, 2015-12, Vol.58 (12), p.569

2015

Volltextzugriff (PDF)

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers

Cancer discovery, 2017-12, Vol.7 (12), p.1464-1479

2017

Volltextzugriff (PDF)

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Nature communications, 2022-07, Vol.13 (1), p.1-16, Article 3869

2022

Volltextzugriff (PDF)

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

The lancet oncology, 2019-06, Vol.20 (6), p.849-861

2019

Volltextzugriff (PDF)

Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment

American journal of medical genetics. Part A, 2011-06, Vol.155A (6), p.1298-1313

2011

Volltextzugriff (PDF)

Forschungssynthesen in der Mediendidaktik: Ansätze und Herausforderungen

2023

Volltextzugriff (PDF)

Factors influencing choice to practise in rural and remote communities throughout a physician's career cycle.(Original Article/Article Original)

Canadian journal of rural medicine, 2017-06, Vol.22 (3), p.92

2017

Volltextzugriff (PDF)

Abstract 1916: β3 integrin/KRAS/RalB complex drives tumor stemness and resistance to EGFR inhibition

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1916-1916

2014

Volltextzugriff (PDF)

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

Journal of medical genetics, 2007-02, Vol.44 (2), p.107-121

2007

Volltextzugriff (PDF)

Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families

International journal of cancer, 2008-01, Vol.122 (1), p.108-116

2008

Volltextzugriff (PDF)

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction

Circulation (New York, N.Y.), 1994-04, Vol.89 (4), p.1567-1572

1994

Volltextzugriff (PDF)

Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families

Familial cancer, 2007, Vol.6 (4), p.483-490

2007

Volltextzugriff (PDF)

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multi step testing approach in French-Canadian families with high risk of breast and ovarian cancer

Journal of medical genetics, 2007, Vol.44 (2), p.107-121

2007

Volltextzugriff (PDF)

PCR Detection of Human Cytomegalovirus DNA in Clinical Specimens Using Novel UL37 Exon 3 and US3 Primers

Clinical and Diagnostic Laboratory Immunology, 1998-03, Vol.5 (2), p.256

1998

Volltextzugriff (PDF)

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges

Familial cancer, 2006, Vol.5 (1), p.3-13

2006

Volltextzugriff (PDF)

Health Behaviors and Psychological Distress in Women Initiating BRCA1/2 Genetic Testing: Comparison with Control Population

Journal of genetic counseling, 2008-08, Vol.17 (4), p.314-326

2008

Volltextzugriff (PDF)

Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5534-5534

2012

Volltextzugriff (PDF)

Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation

Journal of obstetrics and gynaecology Canada, 2007, Vol.29 (1), p.45-60

2007

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Is Biological Subtype Prognostic of Locoregional Recurrence Risk in Women With pT1-2N0 Breast Cancer Treated With Mastectomy?

pN0(i+) Breast Cancer: Treatment Patterns, Locoregional Recurrence, and Survival Outcomes

Individual investigator profiles of biospecimen use in cancer research

Exploring phlebotomy technique as a pre-analytical factor in proteomic analyses by mass spectrometry

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment

Forschungssynthesen in der Mediendidaktik: Ansätze und Herausforderungen

Factors influencing choice to practise in rural and remote communities throughout a physician's career cycle.(Original Article/Article Original)

Abstract 1916: β3 integrin/KRAS/RalB complex drives tumor stemness and resistance to EGFR inhibition

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction

Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multi step testing approach in French-Canadian families with high risk of breast and ovarian cancer

PCR Detection of Human Cytomegalovirus DNA in Clinical Specimens Using Novel UL37 Exon 3 and US3 Primers

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges

Health Behaviors and Psychological Distress in Women Initiating BRCA1/2 Genetic Testing: Comparison with Control Population

Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience

Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation

Suchergebnisse filtern